The Wasatch Global Value Fund—Investor Class returned -5.78% in the fourth quarter of 2024, underperforming the MSCI AC (All ...
Revenue up 28% to $12.9 million in 2024Redomicile to U.S. Nears Completion; Set to Accelerate Market OpportunitiesCompleted $10 Million Private ...
CHANTILLY, Va., March 24, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that its board of directors has increased the company's stock repurchase authorization to $250 ...
Alibaba's stock rally is slowed by geopolitical risks and semiconductor challenges. See why BABA stock's modest upside faces ...
PLC ("TC BioPharm" or the "Company"), (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today ...
Windtree Therapeutics, Inc. ("Windtree” or the "Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating biotech and advancing early and late-stage innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results